The IARC Perspective on Cervical Cancer Screening

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30482-6 · Cited by 4,241 · see citing works

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018

Ferlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., Gavin, A., Visser, O. J., & Bray, F. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.07.005 · Cited by 2,479 · see citing works

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810 · see citing works

HPV Screening for Cervical Cancer in Rural India

Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278 · see citing works

Carcinogenic human papillomavirus infection

Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999 · see citing works

Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities

Gakidou, E., Nordhagen, S., & Obermeyer, Z. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050132 · Cited by 976 · see citing works

Estimates of the global burden of cervical cancer associated with HIV

Stelzle, D., Tanaka, L. F., Lee, K. K., Khalil, A. I., Baussano, I., Shah, A. S. V., McAllister, D., Gottlieb, S. L., Klug, S. J., Winkler, A. S., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30459-9 · Cited by 969 · see citing works

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

Ronco, G., Rossi, P. G., Carozzi, F., Confortini, M., Palma, P. D., Mistro, A. D., Ghiringhello, B., Girlando, S., Gillio‐Tos, A., Marco, L. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 935 · see citing works

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897 · see citing works

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses

Arbyn, M., Smith, S. B., Temin, S., Sultana, F., & Castle, P. (2018) · BMJ · doi:10.1136/bmj.k4823 · Cited by 851 · see citing works

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

Nauclér, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797 · see citing works

Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975

Vecchia, C. L., Bosetti, C., Lucchini, F., Bertuccio, P., Negri, E., Boyle, P., & Levi, F. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp530 · Cited by 559 · see citing works

Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial

Sankaranarayanan, R., Esmy, P. O., Rajkumar, R., Muwonge, R., Swaminathan, R., Shanthakumari, S., Fayette, J.-M., & Cherian, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61195-7 · Cited by 541 · see citing works

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

Rijkaart, D., Berkhof, J. H., Rozendaal, L., van Kemenade, F. J., Bulkmans, N. W. J., Heideman, D. A. M., Kenter, G. G., Cuzick, J. M., Snijders, P. J. F., & Meijer, C. J. L. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70296-0 · Cited by 518 · see citing works

Screening for cervical cancer: a systematic review and meta-analysis

Peirson, L., Fitzpatrick‐Lewis, D., Ciliska, D. K., & Warren, R. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-35 · Cited by 433 · see citing works

Screen-and-Treat Approaches for Cervical Cancer Prevention in Low-Resource Settings: A Randomized Controlled Trial

Denny, L., Kuhn, L., De Souza, M., Pollack, A. E., Dupree, W., & Wright, T. C. (2005) · JAMA · doi:10.1001/jama.294.17.2173 · Cited by 364 · see citing works

Triage of HPV positive women in cervical cancer screening

Wentzensen, N., SCHIFFMAN, M. H., Palmer, T. J., & Arbyn, M. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.11.015 · Cited by 348 · see citing works

Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial

Ronco, G., Segnan, N., Rossi, P. G., Zappa, M., Casadei, G. P., Carozzi, F., Palma, P. D., Mistro, A. D., Folicaldi, S., Gillio‐Tos, A., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj209 · Cited by 312 · see citing works

Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test

Ronco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Palma, P., Mistro, A. D., Gillio‐Tos, A., Minucci, D., Naldoni, C., Rizzolo, R., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn065 · Cited by 306 · see citing works

Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease

Kyrgiou, M., Athanasiou, A., Kalliala, I. E. J., Paraskevaidi, M., Mitra, A., Martin‐Hirsch, P. L., Arbyn, M., Bennett, P. R., & Paraskevaidis, E. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012847 · Cited by 294 · see citing works

Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis

Kelly, H. A., Weiss, H. A., Benavente, Y., de Sanjosé, S., Mayaud, P., Qiao, Y., Feng, R., Vuyst, H. D., Tenet, V., Jaquet, A., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30149-2 · Cited by 289 · see citing works

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months

Ogilvie, G. S., van Niekerk, D., Krajden, M., Smith, L., Cook, D. A., Gondara, L., Ceballos, K. M., Quinlan, D., Lee, M. H., Martin, R. E., et al. (2018) · JAMA · doi:10.1001/jama.2018.7464 · Cited by 283 · see citing works

Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial

Ronco, G., Cuzick, J. M., Pierotti, P., Cariaggi, M. P., Palma, P. D., Naldoni, C., Ghiringhello, B., Rossi, P. G., Minucci, D., Parisio, F., et al. (2007) · BMJ · doi:10.1136/bmj.39196.740995.be · Cited by 278 · see citing works

Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test

Gage, J. C., SCHIFFMAN, M. H., Katki, H. A., Castle, P., Fetterman, B. J., Wentzensen, N., Poitras, N. E., Lorey, T. S., Cheung, L. C., & Kinney, W. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju153 · Cited by 260 · see citing works

Comparison of Liquid-Based Cytology With Conventional Cytology for Detection of Cervical Cancer Precursors

Siebers, A. G., Klinkhamer, P. J. J. M., Grefte, J. M. M., Massuger, L. F. A. G., Vedder, J. E. M., Beijers-Broos, A., Bulten, J., & Arbyn, M. (2009) · JAMA · doi:10.1001/jama.2009.1569 · Cited by 257 · see citing works

The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis

Nelson, E. J., Maynard, B. R., Loux, T., Fatla, J., Gordon, R., & Arnold, L. D. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052609 · Cited by 252 · see citing works

Effect of VIA Screening by Primary Health Workers: Randomized Controlled Study in Mumbai, India

Shastri, S., Mittra, I., Mishra, G. A., Gupta, S. D., Dikshit, R. P., Singh, S., & Badwe, R. A. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju009 · Cited by 244 · see citing works

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

Polman, N. J., Ebisch, R. M. F., Heideman, D. A. M., Melchers, W. J. G., Bekkers, R. L. M., Molijn, A. C., Meijer, C. J. L. M., Quint, W. G. V., Snijders, P. J. F., Massuger, L. F. A. G., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30763-0 · Cited by 227 · see citing works

Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial

Arrossi, S., Thouyaret, L., Herrero, R., Campanera, A., Magdaleno, A., Cuberli, M., Barletta, P., Laudi, R., & Orellana, L. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70354-7 · Cited by 217 · see citing works

A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India

Sankaranarayanan, R., Nene, B. M., Dinshaw, K. A., Mahe, C., Jayant, K., Shastri, S. S., Malvi, S. G., Chinoy, R., Kelkar, R., Budukh, A. M., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21050 · Cited by 206 · see citing works

ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening

Kitchener, H. C., Almonte, M., Gilham, C., Dowie, R., Stoykova, B., Sargent, A., Roberts, C., Desai, M., & Peto, J. (2009) · Health Technology Assessment · doi:10.3310/hta13510 · Cited by 186 · see citing works

Human Papillomavirus–Based Cervical Cancer Prevention: Long-term Results of a Randomized Screening Trial

Denny, L., Kuhn, L., Hu, C.-C., Tsai, W.-Y., & Wright, T. C. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq342 · Cited by 177 · see citing works

Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening

SCHIFFMAN, M. H., Kinney, W., Cheung, L. C., Gage, J. C., Fetterman, B. J., Poitras, N. E., Lorey, T. S., Wentzensen, N., Befano, B., Schussler, J. E., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx225 · Cited by 165 · see citing works

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial

Elfstrom, K. M., Smelov, V., Johansson, A. L. V., Eklund, C., Naucler, P., Arnheim-Dahlstrom, L., & Dillner, J. (2014) · BMJ · doi:10.1136/bmj.g130 · Cited by 142 · see citing works

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands

Dijkstra, M. G., van Zummeren, M., Rozendaal, L., van Kemenade, F. J., Helmerhorst, T. J. M., Snijders, P. J. F., Meijer, C. J. L. M., & Berkhof, J. H. (2016) · BMJ · doi:10.1136/bmj.i4924 · Cited by 123 · see citing works

Validation of Cervical Cancer Screening Methods in HIV Positive Women from Johannesburg South Africa

Firnhaber, C. S., Mayisela, N., Mao, L., Williams, S. T., Swarts, A., Faesen, M., Levin, S., Michelow, P., Omar, T., Hudgens, M. G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053494 · Cited by 114 · see citing works

Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program

Strander, B., Andersson‐Ellström, A., Milsom, I., Rådberg, T., & Ryd, W. (2007) · Cancer · doi:10.1002/cncr.22953 · Cited by 113 · see citing works

Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland

Leinonen, M. K., Nieminen, P., Lönnberg, S., Malila, N. K., Hakama, M., Pokhrel, A., Laurila, P., Tarkkanen, J., & Anttila, A. (2012) · BMJ · doi:10.1136/bmj.e7789 · Cited by 108 · see citing works

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial

Canfell, K., Caruana, M., Gebski, V., Darlington-Brown, J., Heley, S., Brotherton, J. M. L., Gertig, D. M., Jennett, C. J., Farnsworth, A., Tan, J., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002388 · Cited by 100 · see citing works

Does Liquid-Based Technology Really Improve Detection of Cervical Neoplasia?

Obwegeser, J. H., & Brack, S. (2001) · Acta Cytologica · doi:10.1159/000328292 · Cited by 95 · see citing works

Direct comparison of liquid‐based and conventional cytology in a South African screening trial

Taylor, S., Kuhn, L., Dupree, W. B., Denny, L. E., Souza, M. D., & Wright, T. C. (2005) · International Journal of Cancer · doi:10.1002/ijc.21434 · Cited by 84 · see citing works

Cervical cancer risk in women living with HIV across four continents: A multicohort study

Rohner, E., Bütikofer, L., Schmidlin, K., Muchengeti, M. M., Maskew, M., Giddy, J., Taghavi, K., Moore, R. D., Goedert, J. J., Gill, M. J., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32260 · Cited by 78 · see citing works

Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening

Sargent, A., Fletcher, S., Bray, K., Kitchener, H. C., & Crosbie, E. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025388 · Cited by 75 · see citing works

Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India

Basu, P. S., Mittal, S., Banerjee, D., Singh, P., Panda, C. K., Dutta, S., Mandal, R., Das, P., Biswas, J., Muwonge, R., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29458 · Cited by 74 · see citing works

Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy Demonstration Project in Argentina: a population-based, before-and-after retrospective cohort study

Arrossi, S., Paolino, M., Laudi, R., Gago, J. E., Campanera, A., Marín, O., Falcón, C., Serra, V., Herrero, R., & Thouyaret, L. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30048-8 · Cited by 74 · see citing works

A randomised comparison of SurePath liquid‐based cytology and conventional smear cytology in a colposcopy clinic setting

Sykes, P. H., Harker, D., Miller, A., Whitehead, M. R., Neal, H., Wells, J., & Peddie, D. J. (2008) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01865.x · Cited by 48 · see citing works

Evaluation of cervical screening in rural North India

Bhatla, N., Gulati, A., Mathur, S. R., Rani, S., Krishnan, A., Muwonge, R., & Sankaranarayanan, R. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2008.12.010 · Cited by 48 · see citing works

Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany

Iftner, T., Neis, K.-J., Castañón, A., Landy, R., Holz, B., Woll-Herrmann, A., Iftner, A., Staebler, A., Wallwiener, D. R., von Weyhern, C. H., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01177-18 · Cited by 40 · see citing works

Diagnostic accuracy of cervical cancer screening and screening–triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study

Kelly, H. A., Chikandiwa, A. T., Sawadogo, B., Gilham, C., Michelow, P. M., Lompo, O., Omar, T., Zan, S., Magooa, P., Segondy, M., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003528 · Cited by 39 · see citing works

A randomized trial comparing conventional cytology to liquid‐based cytology and computer assistance

Klug, S. J., Neis, K. J., Harlfinger, W., Malter, A., König, J., Spieth, S., Brinkmann‐Smetanay, F., Kommoss, F., Weyer, V., & Ikenberg, H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27955 · Cited by 37 · see citing works

HPV‐mRNA and HPV‐DNA detection in samples taken up to seven years before severe dysplasia of cervix uteri

Forslund, O., Elfström, K. M., Lamin, H., & Dillner, J. (2018) · International Journal of Cancer · doi:10.1002/ijc.31819 · Cited by 34 · see citing works

Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study

El‐Zein, M., Bouten, S., Louvanto, K., Gilbert, L., Gotlieb, W. H., Hemmings, R., Behr, M. A., & Franco, E. L. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.04.004 · Cited by 30 · see citing works

Having a Pap smear, quality of life before and after cervical screening: a questionnaire study

Korfage, I., van Ballegooijen, M., Wauben-Spaetgens, B., Looman, C., Habbema, J., & Essink‐Bot, M. (2012) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2012.03344.x · Cited by 29 · see citing works

Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial

Cook, D. A., Smith, L., Law, J. H., Mei, W., Gondara, L., van Niekerk, D. J., Ceballos, K. M., Jang, D., Chernesky, M., Franco, E. L., et al. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.09.004 · Cited by 29 · see citing works

Primary HPV testing with cytology versus cytology alone in cervical screening—A prospective randomized controlled trial with two rounds of screening in a Chinese population

Chan, K. K. L., Liu, S. S., Wei, N., Ngu, S., Chu, M. M. Y., Tse, K. Y., Lau, L. S. K., Cheung, A., & Ngan, H. (2020) · International Journal of Cancer · doi:10.1002/ijc.32861 · Cited by 26 · see citing works

Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus

Luckett, R. L., Mogowa, N., Li, H. J., Erlinger, A. L., Hacker, M. R., Esselen, K. M., Feldman, S., Shapiro, R., Morroni, C., & Ramogola‐Masire, D. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003496 · Cited by 24 · see citing works

Psycho-social impact of positive human papillomavirus testing in Jujuy, Argentina results from the Psycho-Estampa study

Arrossi, S., Almonte, M., Herrero, R., Gago, J. E., Antelo, V. S., Szwarc, L., Thouyaret, L., Paolino, M., & Wiesner, C. (2020) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2020.101070 · Cited by 23 · see citing works

Risk of CIN2 or more severe lesions after negative HPV‐mRNA E6/E7 overexpression assay and after negative HPV‐DNA test: Concurrent cohorts with a 5‐year follow‐up

Zorzi, M., Mistro, A. D., Rossi, P. G., Laurino, L., Battagello, J., Lorio, M., Soldà, M., Gabellotti, E. M., Maran, M., Cin, A. D., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32695 · Cited by 16 · see citing works

Comparison of the Conventional Cervical Smear and Liquid-Based Cytology

Maccallini, V., Angeloni, C., Caraceni, D., Fortunato, C., Venditti, M. A., Gabriele, G. D., Antonelli, C., Lattanzi, A., Puliti, D., Ciatto, S., et al. (2008) · Acta Cytologica · doi:10.1159/000325599 · Cited by 16 · see citing works

Effectiveness of cervical cancer screening at age 65 — A register-based cohort study

Pankakoski, M., Anttila, A., Sarkeala, T. M., & Heinävaara, S. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214486 · Cited by 16 · see citing works

[Real-world research on cervical cancer screening program and effect evaluation for Chinese population].

Zhao, Y., Dai, Y., Dang, L., Kong, L. H., Zhang, Y., Feng, R., Qiao, Y., & Lang, J. (2018) · PubMed · doi:10.3760/cma.j.issn.0253-3766.2018.10.008 · Cited by 16 · see citing works

Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China

Zhang, L., Xu, X., Hu, S., Chen, F., Zhang, X., Pan, Q., Zhang, W., Feng, R., Dong, L., Zhang, Q., et al. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.09.012 · Cited by 15 · see citing works

Optional screening strategies for cervical cancer using standalone tests and their combinations among low- and medium-income populations in Latin America and Eastern Europe

Sarian, L. O., Derchain, S., Shabalova, I. P., Tatti, S., Naud, P., Longatto‐Filho, A., Syrjänen, S., & Syrjänen, K. J. (2010) · Journal of Medical Screening · doi:10.1258/jms.2010.010016 · Cited by 13 · see citing works

Adjunct screening of cervical or vaginal samples using careHPV testing with Pap and aided visual inspection for detecting high-grade cervical intraepithelial neoplasia

Asthana, S., & Labani, S. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.11.006 · Cited by 13 · see citing works

An on-going study of three different cervical cancer screening strategies based on primary healthcare facilities in Beijing China

Han, L., Chang, X., Song, P., Gao, L., Zhang, Y., An, L., & Shen, J. (2019) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.09.003 · Cited by 8 · see citing works

Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative

Singh, D., Vignat, J., Lorenzoni, V., Eslahi, M., Ginsburg, O., Lauby-Secretan, B., Arbyn, M., Basu, P., Bray, F., & Vaccarella, S. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00501-0 · Cited by 1,616 · see citing works

Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis

Bruni, L., Serrano, B., Roura, E., Alemany, L., Cowan, M., Herrero, R., Poljak, M., Murillo, R., Broutet, N., Riley, L. M., et al. (2022) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00241-8 · Cited by 558 · see citing works

Cervical Cancer Screening

Perkins, R. B., Wentzensen, N., Guido, R. S., & Schiffman, M. (2023) · JAMA · doi:10.1001/jama.2023.13174 · Cited by 501 · see citing works

Worldwide use of HPV self-sampling for cervical cancer screening

Serrano, B., Ibáñez, R., Robles, C., Peremiquel‐Trillas, P., de Sanjosé, S., & Bruni, L. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106900 · Cited by 298 · see citing works

IARC Perspective on Oral Cancer Prevention

Bouvard, V., Nethan, S. T., Singh, D., Warnakulasuriya, S., Mehrotra, R., Chaturvedi, A. K., Chen, T. H.-H., Ayo-Yusuf, O. A., Gupta, P. C., Kerr, A. R., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmsr2210097 · Cited by 166 · see citing works

Advances in cervical cancer: current insights and future directions

Xu, M., Cao, C., Wu, P., Huang, X., & Ma, D. (2024) · 癌症：英文版 · doi:10.1002/cac2.12629 · Cited by 176 · see citing works

Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022

Wu, J., Jin, Q., Zhang, Y., Ji, Y., Li, J., Liu, X., Duan, H., Feng, Z., Ya, L., Zhang, Y., et al. (2025) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.11.006 · Cited by 182 · see citing works

Dendritic Cells in Cancer Immunology and Immunotherapy

Hato, L., Atienza, Á. V., Eguren‐Santamaría, I., Perez‐Gracia, J. L., Rodríguez, J., Pérez‐Larraya, J. G., Sarobe, P., Inogés, S., de Cerio, A. L. D., & Santisteban, M. (2024) · Cancers · doi:10.3390/cancers16050981 · Cited by 143 · see citing works

Updates on cervical cancer prevention

Viveros-Carreño, D. A., Fernándes, A., & Pareja, R. (2023) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2022-003703 · Cited by 127 · see citing works

Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population

Simms, K. T., Keane, A., Nguyen, D. T. N., Caruana, M., Hall, M. T., Lui, G., Gauvreau, C., Demke, O., Arbyn, M., Basu, P., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02600-4 · Cited by 105 · see citing works

Cervical cancer screening using DNA methylation triage in a real-world population

Schreiberhuber, L., Barrett, J. J. E., Wang, J., Redl, E., Herzog, C. M. S., Vavourakis, C. D., Sundström, K., Dillner, J., & Widschwendter, M. (2024) · Nature Medicine · doi:10.1038/s41591-024-03014-6 · Cited by 106 · see citing works

Cervical cancer: a new era

Caruso, G., Wagar, M. K., Hsu, H., Hoegl, J., Valzacchi, G. M. R., Fernándes, A., Cucinella, G., Aker, S. Ş., Jayraj, A. S., Mauro, J., et al. (2024) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2024-005579 · Cited by 78 · see citing works

Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines

Massad, L. S., Clarke, M. A., Perkins, R. B., García, F., Chelmow, D. P., Cheung, L. C., Darragh, T. M., Egemen, D., Lorey, T. S., Nayar, R., et al. (2025) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000865 · Cited by 71 · see citing works

Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee

Wentzensen, N., Massad, L. S., Clarke, M. A., Garcia, F. M. P., Smith, R. A., Murphy, J., Guido, R. S., Reyes, A., Phillips, S. M., Berman, N. R., et al. (2025) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000885 · Cited by 62 · see citing works

Cervical Cancer

Sahasrabuddhe, V. V. (2024) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2024.03.005 · Cited by 76 · see citing works

A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma

Zou, J., Lin, Z., Jiao, W., Chen, J., Lin, L., Zhang, F., Zhang, X., & Zhao, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-20566-0 · Cited by 58 · see citing works

Artificial intelligence–based image analysis in clinical testing: lessons from cervical cancer screening

Egemen, D., Perkins, R. B., Cheung, L. C., Befano, B., Rodríguez, A. C., Desai, K. T., Lemay, A., Ahmed, S. R., Antani, S., Jerónimo, J., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad202 · Cited by 55 · see citing works

An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings

Kundrod, K. A., Barra, M., Wilkinson, A. F., Smith, C. A., Natoli, M. E., Chang, M. M., Coole, J. B., Santhanaraj, A., Lorenzoni, C. F., Mavume, C., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn4768 · Cited by 53 · see citing works

Recent trends in cervical cancer incidence, stage at diagnosis, and mortality according to county‐level income in the United States, 2000–2019

Amboree, T. L., Damgacioglu, H., Sonawane, K., Adsul, P., Montealegre, J. R., & Deshmukh, A. A. (2024) · International Journal of Cancer · doi:10.1002/ijc.34860 · Cited by 50 · see citing works

Public health concern-driven insights and response of low- and middle-income nations to the World health Organization call for cervical cancer risk eradication

Reza, S., Anjum, R., Khandoker, R. Z., Khan, S. R., Islam, M. R., & Dewan, S. M. R. (2024) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2024.101460 · Cited by 49 · see citing works

Cervical extracellular matrix hydrogel optimizes tumor heterogeneity of cervical squamous cell carcinoma organoids

Song, H., Jiang, H., Hu, W., Hai, Y., Cai, Y., Li, H., Liao, Y. R., Huang, Y., Lv, X., Zhang, Y., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl3511 · Cited by 48 · see citing works

Prevalence and genotype distribution of human papillomavirus infections in Beijing, China between 2016 and 2020

Zhang, W., Guo, N., Li, B., Shang, E., Wang, J., Zhang, M., & Yang, X. (2023) · Virology Journal · doi:10.1186/s12985-023-01959-7 · Cited by 47 · see citing works

Human Oncogenic Viruses: Characteristics and Prevention Strategies—Lessons Learned from Human Papillomaviruses

Galati, L., Chiantore, M. V., Marinaro, M., & Bonito, P. D. (2024) · Viruses · doi:10.3390/v16030416 · Cited by 56 · see citing works

Cervical Cancer Screening Recommendations: Now and for the Future

Rayner, M., Welp, A. M., Stoler, M. H., & Cantrell, L. A. (2023) · Healthcare · doi:10.3390/healthcare11162273 · Cited by 55 · see citing works

Secondary Prevention of Cervical Cancer: ASCO Resource–Stratified Guideline Update

Shastri, S. S., Temin, S., Almonte, M., Basu, P. S., Campos, N. G., Gravitt, P. E., Gupta, V., Lombe, D. C., Murillo, R., Nakisige, C., et al. (2022) · JCO Global Oncology · doi:10.1200/go.22.00217 · Cited by 42 · see citing works

Strategies to eliminate cervical cancer in China

Ji, L., Chen, M., & Yao, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1105468 · Cited by 45 · see citing works

Deep learning enabled liquid-based cytology model for cervical precancer and cancer detection

Xue, P., Dang, L., Kong, L.-H., Tang, H., Xu, H., Weng, H., Wang, Z., Wei, R., Xu, L., Li, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58883-3 · Cited by 45 · see citing works

Associated factors and global adherence of cervical cancer screening in 2019: a systematic analysis and modelling study

Zhang, W., Gao, K., Fowkes, F. J. I., Adeloye, D., Rudan, I., Song, P., Jin, M., & Chen, K. (2022) · Globalization and Health · doi:10.1186/s12992-022-00890-w · Cited by 41 · see citing works

HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions

Arbyn, M., Costa, S., Latsuzbaia, A., Kellen, E., Rossi, P. G., Cocuzza, C. E., Basu, P. S., & Castle, P. E. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-1041 · Cited by 41 · see citing works

Cell-free DNA: a promising biomarker in infectious diseases

Hu, Y., Zhao, Y., Zhang, Y., Chen, W., Zhang, H., & Jin, X. K. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2024.06.005 · Cited by 40 · see citing works

Risk factors for the development of cervical cancer: analysis of the evidence

Luvián‐Morales, J., Gutiérrez-Enríquez, S. O., Granados-García, V., & Torres-Poveda, K. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1378549 · Cited by 38 · see citing works

Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control

Castle, P. E. (2024) · Viruses · doi:10.3390/v16091357 · Cited by 38 · see citing works

Impact of cervical screening by human papillomavirus genotype: Population-based estimations

Wang, J., Elfström, K. M., Lagheden, C., Eklund, C., Sundström, K., Sparén, P., & Dillner, J. (2023) · PLoS Medicine · doi:10.1371/journal.pmed.1004304 · Cited by 36 · see citing works

Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and Process

Wentzensen, N., García, F., Clarke, M. A., Massad, L. S., Cheung, L. C., Egemen, D., Guido, R. S., Huh, W. K., Saslow, D., Smith, R. A., et al. (2024) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000804 · Cited by 33 · see citing works

An Overview of HPV Screening Tests to Improve Access to Cervical Cancer Screening Amongst Underserved Populations: From Development to Implementation

Okunade, K. S., Adejimi, A. A., John‐Olabode, S., Oshodi, Y. A., & Oluwole, A. A. (2022) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s296914 · Cited by 36 · see citing works

Cancer screening programs in South-east Asia and Western Pacific

Wee, H. L., Canfell, K., Chiu, H., Choi, K. S., Cox, B., Bhoo‐Pathy, N., Simms, K. T., Hamashima, C., Shen, Q., Chua, B. W. B., et al. (2024) · BMC Health Services Research · doi:10.1186/s12913-023-10327-8 · Cited by 32 · see citing works

Detection of endometrial cancer using tampon-based collection and methylated DNA markers

Bakkum-Gamez, J. N., Sherman, M. E., Slettedahl, S. W., Mahoney, D. W., Lemens, M. A., Laughlin-Tommaso, S. K., Hopkins, M. R., VanOosten, A. L., Shridhar, V., Staub, J. K., et al. (2023) · Gynecologic Oncology · doi:10.1016/j.ygyno.2023.04.014 · Cited by 30 · see citing works

Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening

Arbyn, M., Cuschieri, K. S., Bonde, J. H., Schuurman, R., Cocuzza, C. E., Broeck, D. V., Zhao, F., Rezhake, R., Gültekin, M., de Sanjosé, S., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29881 · Cited by 31 · see citing works

Use of risk-based cervical screening programs in resource-limited settings

Perkins, R. B., Smith, D. L., Jerónimo, J., Campos, N. G., Gage, J. C., Hansen, N., Rodríguez, A. C., Cheung, L. C., Egemen, D., Befano, B., et al. (2023) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102369 · Cited by 29 · see citing works

Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV

Hall, M. T., Simms, K. T., Murray, J. M., Keane, A., Nguyen, D. T. N., Caruana, M., Lui, G., Kelly, H. A., Eckert, L. O., Santesso, N. A., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02601-3 · Cited by 29 · see citing works

Integrated immunological analysis of single-cell and bulky tissue transcriptomes reveals the role of interactions between M0 macrophages and naïve CD4+ T cells in the immunosuppressive microenvironment of cervical cancer

Chen, H., Ma, R., Zhou, B., Yang, X., Duan, F., & Wang, G. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107151 · Cited by 27 · see citing works

Current Status of the National Cancer Screening Program in Korea: History, Achievements, and Future Directions

Lee, K., Suh, M., & Choi, K. S. (2025) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.25.268 · Cited by 26 · see citing works

Cervical Cancer Screening with DNA-HPV Testing and Precancerous Lesions Detection: A Brazilian Population-based Demonstration Study

Teixeira, J. C., Vale, D. B., Discacciati, M. G., Campos, C. S., Bragança, J. F., & Zeferino, L. C. (2023) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0043-1763493 · Cited by 25 · see citing works

Coverage and Socioeconomic Inequalities in Cervical Cancer Screening in Low- and Middle-Income Countries Between 2010 and 2019

Abila, D. B., Wasukira, S. B., Ainembabazi, P., Nakiyingi, E. K., Chemutai, B., Kyagulanyi, E., Varsani, J. V., Shindodi, B., Kisuza, R. K., & Niyonzima, N. (2024) · JCO Global Oncology · doi:10.1200/go.23.00385 · Cited by 24 · see citing works

Addressing global disparities in cervical cancer burden: a narrative review of emerging strategies

Gopalkrishnan, K., & Karim, R. (2025) · Current HIV/AIDS Reports · doi:10.1007/s11904-025-00727-2 · Cited by 24 · see citing works

Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: A population-based survey

Znaor, A., Ryzhov, A., Losada, M. L., Carvalho, A. L., Smelov, V., Барчук, А. А., Valkov, М. Y., Ten, E., Andreasyan, D., Zhizhilashvili, S., et al. (2023) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2023.100436 · Cited by 23 · see citing works

Cervical Cancer in the Era of HPV: Translating Molecular Mechanisms into Preventive Public Health Action

Boldeanu, L., Assani, M.-Z., Boldeanu, M. V., Siloşi, I., Manolea, M. M., Văduva, C.-C., Assani, A.-D., & Dijmărescu, A. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178463 · Cited by 23 · see citing works

State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI

Engels, E. A., Shiels, M. S., Barnabas, R. V., Bohlius, J., Brennan, P., Castilho, J. L., Chanock, S. J., Clarke, M. A., Coghill, A. E., Combes, J., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34727 · Cited by 23 · see citing works

Trop-2 expression and the tumor immune microenvironment in cervical cancer

Chiba, Y., Kojima, Y., Yazaki, S., Yoshida, H., Takamizawa, S., Kitadai, R., Saito, A., Okuma, H. S., Nishikawa, T., Shimoi, T., et al. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.04.022 · Cited by 23 · see citing works

Population-Based Trends in Cervical Cancer Incidence and Mortality in Brazil: Focusing on Black and Indigenous Population Disparities

de Melo, A. C., da Silva, J. L., dos Santos, A. L. S., & Thuler, L. C. S. (2023) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-023-01516-6 · Cited by 22 · see citing works

SlipChip Enables the Integration of CRISPR-Cas12a and RPA for Fast and Stand-Alone HPV Detection

Zhao, Y., Li, Z., Li, T., Rao, R., Zhu, J., Hu, R., Xu, G., Li, Y., & Yang, Y. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c05290 · Cited by 21 · see citing works

HPV vaccination, screening disparities, and the shifting landscape of cervical cancer burden: a global analysis of trends, inequalities, and policy implications

Zhang, Y., Fan, Z., Wang, J., Guan, B., Zhou, F., Tang, Z., Wu, W., & Huang, A. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03841-w · Cited by 21 · see citing works

Dual-enzyme cascade amplification electrochemical biosensor for human papillomavirus based on DNA nanoflower structure

He, H., Cheng, L., He, Y., Chen, J., Song, L., Yang, Y., Zhang, Y., Lin, Z., & Hong, G. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132532 · Cited by 20 · see citing works

A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia

Nickson, C., Smith, M. A., Feletto, E., Velentzis, L. S., Broun, K., Deij, S., Grogan, P. B., Hall, M. T., He, E., John, D. J. S., et al. (2023) · eLife · doi:10.7554/elife.82818 · Cited by 20 · see citing works

Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries

Mallafré‐Larrosa, M., Ritchie, D., Papi, G., Mosquera, I., Mensah, K., Lucas, E., Bøje, R. B., Kirkegaard, P., Andersen, B. S., Basu, P. S., et al. (2023) · European Journal of Public Health · doi:10.1093/eurpub/ckad055 · Cited by 20 · see citing works

Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study

Benevolo, M., Ronco, G., Mancuso, P., Carozzi, F., De Marco, L., Allia, E., Bisanzi, S., Rizzolo, R., Gustinucci, D., Del Mistro, A., et al. (2024) · eBioMedicine · doi:10.1016/j.ebiom.2024.105149 · Cited by 19 · see citing works

No woman left behind: achieving cervical cancer elimination among women living with HIV

Sharma, K., Machalek, D. A., Toh, Z. Q., Amenu, D., Muchengeti, M. M., Ndlovu, A. K., Mremi, A., Mchome, B. L., Vallely, A. J., Denny, L. E., et al. (2023) · The Lancet HIV · doi:10.1016/s2352-3018(23)00082-6 · Cited by 19 · see citing works

Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination

El‐Zein, M., & Franco, E. L. (2025) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2025.2486653 · Cited by 19 · see citing works

Development of a multimodal mobile colposcope for real-time cervical cancer detection

Coole, J. B., Brenes, D., Resende, J. C. P., Antoniazzi, M., Fonseca, B. D. O., Maker, Y. N., Kortum, A., Vohra, I. S., Schwarz, R. A., Carns, J., et al. (2022) · Biomedical Optics Express · doi:10.1364/boe.463253 · Cited by 18 · see citing works

Cervical cancer elimination in Indian context: Moving from barriers to facilitators

Vikraman, S. M., Khanna, D., & Dandpat, A. (2022) · Cancer · doi:10.1002/cncr.34486 · Cited by 18 · see citing works

Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework

Latsuzbaia, A., Broeck, D. V., Keer, S. V., Weyers, S., Donders, G. G. G., Doyen, J., Tjalma, W. A. A., Sutter, P. D., Vorsters, A., & Arbyn, M. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2023.06.004 · Cited by 21 · see citing works

Sexually transmitted infections and the HPV-related burden: evolution of Italian epidemiology and policy

Gazzetta, S., Valent, F., Sala, A., Driul, L., & Brunelli, L. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1336250 · Cited by 18 · see citing works

Transition from opportunistic cytological to organized screening program with DNA-HPV testing detected prevalent cervical cancers 10 years in advance

Teixeira, J. C., Vale, D. B., Campos, C. S., Polegatto, I., Bragança, J. F., Discacciati, M. G., & Zeferino, L. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-71735-2 · Cited by 21 · see citing works

Development, validation, and clinical application of a machine learning model for risk stratification and management of cervical cancer screening based on full-genotyping hrHPV test (SMART-HPV): a modelling study

Dong, B., Lü, Z., Yang, T., Wang, J., Zhang, Y., Tuo, X., Wang, J., Lin, S., Cai, H., Huan, C., et al. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101480 · Cited by 20 · see citing works

Trends and Determinants in Uptake of Cervical Cancer Screening in Spain: An Analysis of National Surveys from 2017 and 2020

de la Cruz, S. P., & Cebrino, J. (2022) · Cancers · doi:10.3390/cancers14102481 · Cited by 17 · see citing works

HPV Vaccination and Cervical Cancer Screening Policies and Practices in 18 Countries, Territories and Entities across Eastern Europe and Central Asia

Davies, P. O., Алулоски, И., Aluloski, D., Brcanski, J., Davidzenka, A., Durdyeva, A., Umarzoda, S. G., Goshliyev, K., Jovanović, V., Jugeli, L., et al. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.5.1781 · Cited by 17 · see citing works

Pivotal Clinical Study to Evaluate the Efficacy and Safety of Assistive Artificial Intelligence-Based Software for Cervical Cancer Diagnosis

Kim, S., An, H., Cho, H., Min, K., Hong, J. H., Lee, S., Song, J. Y., Lee, J. K., & Lee, N. W. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124024 · Cited by 17 · see citing works

Predicting cervical cancer risk probabilities using advanced H20 AutoML and local interpretable model-agnostic explanation techniques

Prusty, S., Patnaik, S., Dash, S. K., Prusty, S. G. P., Rautaray, J., & Sahoo, G. (2024) · PeerJ Computer Science · doi:10.7717/peerj-cs.1916 · Cited by 17 · see citing works

Understanding the Challenges of HPV-Based Cervical Screening: Development and Validation of HPV Testing and Self-Sampling Attitudes and Beliefs Scales

Tatar, O., Haward, B., Zhu, P., Griffin-Mathieu, G., Perez, S., McBride, E., Lofters, A., Smith, L., Mayrand, M., Daley, E. M., et al. (2023) · Current Oncology · doi:10.3390/curroncol30010093 · Cited by 16 · see citing works

Correlation analysis of vaginal microecology and different types of human papillomavirus infection: a study conducted at a hospital in northwest China

Feng, F., Hou, Y.-M., Zhang, Y., Wang, L., Li, P.-P., Guo, Y. C., & An, R. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1138507 · Cited by 16 · see citing works

Knowledge about cervical cancer risk factors and human papilloma virus vaccine among Saudi women of childbearing age: A community-based cross-sectional study from Saudi Arabia

Gari, A. M., Ghazzawi, M. A., Ghazzawi, S. A., Alharthi, S. M., Yanksar, E. A., Almontashri, R. M., Batarfi, R., Kinkar, L. I., & Baradwan, S. (2023) · Vaccine X · doi:10.1016/j.jvacx.2023.100361 · Cited by 16 · see citing works

Long‐term prediction by DNA methylation of high‐grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort

Gilham, C., Nedjai, B., Scibior‐Bentkowska, D., Reuter, C., Banwait, R., Brentnall, A. R., Cuzick, J. M., Peto, J., & Lörincz, A. T. (2024) · International Journal of Cancer · doi:10.1002/ijc.34913 · Cited by 16 · see citing works

Cancer Screening Companies Are Rapidly Proliferating: Are They Ready for Business?

Fernandez-Uriarte, A., Pons-Belda, O. D., & Diamandis, E. P. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0102 · Cited by 16 · see citing works

Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations

Zigras, T., Mayrand, M., Bouchard, C., Salvador, S. C., Eiriksson, L. R., Almadin, C., Kean, S., Dean, E. A., Malhotra, U., Todd, N. J., et al. (2023) · Current Oncology · doi:10.3390/curroncol30060425 · Cited by 15 · see citing works

Long‐term follow‐up of cervical cancer incidence after normal cytological findings

Wang, J., Edvardsson, H., Strander, B., Andrae, B., Sparén, P., & Dillner, J. (2023) · International Journal of Cancer · doi:10.1002/ijc.34723 · Cited by 14 · see citing works

Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal Swabs

Qi, M., Naranjo, A. R., Duque, A. J., Lorey, T. S., Schapiro, J. M., Suh-Burgmann, B. J., Rummel, M., Salipante, S. J., Wentzensen, N., & Greene, D. N. (2024) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2024.02.006 · Cited by 15 · see citing works

Epidemiological study of HPV infection in 40,693 women in Putian: a population study based on screening for high-risk HPV infection

Chen, Z., Lin, H., Zheng, J., Cai, L., Chen, Z., Li, J., & Yu, L. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07893-3 · Cited by 18 · see citing works

The IARC Perspective on Cervical Cancer Screening

Suba, E. J., Ortega, R. E., & Mutch, D. G. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2119177 · Cited by 15 · see citing works

Evaluating PAX1/JAM3 methylation for triage in HPV 16/18-infected women

Jing, F., Zhai, L., Wang, J., Zhu, X., Liu, P., Wang, L., Ma, D., Li, L., & Zhou, J. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01804-w · Cited by 14 · see citing works

Harnessing Aggregation‐Induced Emission‐Based Detection Toolbox for Diagnostics of Urogenital Tumors

Chen, W., Guan, H., Lu, Y., Zeng, G., Gu, D., Guo, K., Jiang, C., & Liu, H. (2025) · Aggregate · doi:10.1002/agt2.70008 · Cited by 14 · see citing works

Diagnostic accuracy of menstrual blood for human papillomavirus detection in cervical cancer screening: a systematic review

Chakravarti, P., Maheshwari, A., Tahlan, S., Kadam, P. R., Bagal, S. S., Gore, S., Panse, N. S., Deodhar, K., Chaturvedi, P., Dikshit, R. P., et al. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1427 · Cited by 14 · see citing works

Unsupervised Domain Adaptive Dose Prediction via Cross-Attention Transformer and Target-Specific Knowledge Preservation

Cui, J., Xiao, J., Hou, Y. F., Xi, W., Zhou, J., Peng, X., & Wang, Y. (2023) · International Journal of Neural Systems · doi:10.1142/s0129065723500570 · Cited by 14 · see citing works

Cervical cancer prevention in the United States—where we've been and where we're going: The American Cancer Society Primary HPV Screening Initiative

Nayar, R. (2023) · Cancer Cytopathology · doi:10.1002/cncy.22733 · Cited by 13 · see citing works

Cervical cancer in Thailand: 2023 update

Wongpratate, M., & Bumrungthai, S. (2024) · Obstetrics & Gynecology Science · doi:10.5468/ogs.23277 · Cited by 13 · see citing works

The socioeconomic burden of cervical cancer and its implications for strategies required to achieve the WHO elimination targets

Brotherton, J. M. L., Vajdic, C. M., & Nightingale, C. E. (2025) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2025.2451732 · Cited by 14 · see citing works

Cervical cancer prevention program in Mexico disrupted due to COVID-19 pandemic: Challenges and opportunities

Cruz-Valdéz, A., Palacio-Mejía, L. S., Quezada-Sanchez, A. D., Hernández‐Ávila, J. E., Galicia-Carmona, T., Cetina, L., Arango-Bravo, E. A., Isla‐Ortiz, D., Aranda-Flores, C. E., Uscanga-Sánchez, S., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1008560 · Cited by 13 · see citing works

Analyzing and forecasting global cervical cancer burden based on WHO’s elimination strategy: insights and projections from a 1990–2021 global burden of disease (GBD) study covering 204 countries and territories

Huang, Y., Lin, W., Chen, X., Zheng, X., Yi, H., & Zhang, L. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.09.038 · Cited by 15 · see citing works

Recent HPV self-sampling use for cervical cancer screening in Latin America and Caribbean: a systematic review

Dartibale, C. B., Prado, G. D. C., Carobeli, L. R., Meirelles, L. E. D. F., Damke, G. M. Z. F., Damke, E., Morelli, F., Souza, R. P., Group PREVENT YOURSELF, da Silva, V. R. S., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.948471 · Cited by 14 · see citing works

Crosstalk between cancer stem cells and the tumor microenvironment drives progression of premalignant oral epithelium

Polverini, P., Nör, F., & Nör, J. (2023) · Frontiers in Oral Health · doi:10.3389/froh.2022.1095842 · Cited by 11 · see citing works

The Mulher Study: cervical cancer screening with primary HPV testing in Mozambique

Salcedo, M. P., Lathrop, E., Osman, N. B., Neves, A., Rangeiro, R., Mariano, A. A. N., Nkundabatware, J. C., Tivir, G., Carrilho, C., Monteiro, E. C. S., et al. (2023) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2023-004958 · Cited by 12 · see citing works

Screening Methods for Cervical Cancer

Li, J., Adobo, S. D., Shi, H., Judicael, K. A. W., Lin, N., & Gao, L. (2024) · ChemMedChem · doi:10.1002/cmdc.202400021 · Cited by 12 · see citing works

Triage performance of DNA methylation for women with high-risk human papillomavirus infection

Kong, L., Xiao, X., Wu, H., You, Y., Jin, X., Liou, Y., Liu, P., Lang, J., & Li, L. (2024) · The Oncologist · doi:10.1093/oncolo/oyae324 · Cited by 12 · see citing works

Alpha-linolenic acid-mediated epigenetic reprogramming of cervical cancer cell lines

Ulhe, A., Raina, P., Chaudhary, A., & Kaul-Ghanekar, R. (2025) · Epigenetics · doi:10.1080/15592294.2025.2451551 · Cited by 12 · see citing works

DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test

Herzog, C. M. S., Sundström, K., Jones, A., Evans, I., Barrett, J. J. E., Wang, J., Redl, E., Schreiberhuber, L., Costas, L., Paytubi, S., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01353-0 · Cited by 12 · see citing works

The time has come to implement primary human papillomavirus screening for cervical cancer in the United States

Franco, E. L., & American Cancer Society's Primary HPV Screening Initiative (2023) · Cancer · doi:10.1002/cncr.34899 · Cited by 12 · see citing works

Elimination of cervical cancer: the impact of HPV vaccination, primary HPV screening, and expanded access to cancer treatment services

Hall, M. T., Hyatt, A., Smith, M. A., Torode, J., Costa, T., Nguyen, D., Balshaw, T., Grogan, P. B., Sweeny, K., Auste, C., et al. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101423 · Cited by 13 · see citing works

Pricing of HPV tests in Italian tender-based settings

Inturrisi, F., & Berkhof, J. H. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2082777 · Cited by 11 · see citing works

Analysis of the effectiveness of the application of pelvic floor rehabilitation exercise and the factors influencing its self-efficacy in postoperative patients with cervical cancer

Li, X., Liu, L., He, J., Yan, J., & Wang, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1118794 · Cited by 11 · see citing works

The association of cervical cancer screening and quality of care: A systematic analysis of the Global Burden of Disease Study 2019

Wang, M., Jin, Y., & Zheng, Z. (2023) · Journal of Global Health · doi:10.7189/jogh.13.04090 · Cited by 11 · see citing works

Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?

Godoy, L. R., Resende, J. C. P., Guimarães, Y. M., Pedrão, P. G., dos Reis, R., & Longatto‐Filho, A. (2022) · Cancers · doi:10.3390/cancers14112612 · Cited by 14 · see citing works

The Challenges of Cervical Cancer Screening

Wilson, M. L. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcphtjcyilm5frf

Contemporary Status and Frontiers of Cervical Cancer Screening in the United States

Eli, A. V., Kasten, B. B., Mayer, C., Samant, R. R., Hartman, Y. E., Chaudhary, I., Imran, N., Zotto, V. L. D., Kahn, A. G., Arend, R. C., et al. (2025) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-25-0118

Advances in cervical cancer screening and human papillomavirus vaccines

Feeley, C. (2006) · The Journal of the British Menopause Society · doi:10.1258/136218006775997252 · Cited by 4 · see citing works

Modeling cervical cancer elimination: a pathway to inform policy decisions

Zhong, P., Zhang, L., & Zhao, F. (2025) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2025.0387 · Cited by 1 · see citing works

Update on prevention and screening of cervical cancer

McGraw, S. L. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i4.744 · Cited by 153 · see citing works